oxoglaucine has been researched along with Candidiasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hristova, M; Ivanovska, N; Philipov, S | 1 |
| Hristova, M; Ivanovska, N | 1 |
2 other study(ies) available for oxoglaucine and Candidiasis
| Article | Year |
|---|---|
Immunosuppression and recovery of drug-impaired host resistance against Candida albicans infection by oxoglaucine.
Topics: Animals; Apomorphine; Brain; Candidiasis; Cyclophosphamide; Female; Hypersensitivity, Delayed; Immunosuppressive Agents; Kidney; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Inbred ICR | 2000 |
Treatment with oxoglaucine can enhance host resistance to Candida albicans infection of mice with adjuvant arthritis.
Topics: Adjuvants, Immunologic; Animals; Apomorphine; Arthritis, Experimental; Biological Assay; Candida albicans; Candidiasis; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Flow Cytometry; Mice; Tumor Necrosis Factor-alpha | 2000 |